Steroid refractory acute graft-versus-host disease - survey Type d'étude Maladies Groupe Transplant Complications Working Party (TCWP) Type de traitement Allogeneic Investigateur principal Zinaida Peric
Renal failure in aplastic anemia Type d'étude Maladies Bone marrow failure Groupe Severe Aplastic Anaemia Working Party (SAAWP) Type de traitement Investigateur principal Beatrice Drexler
Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia Type d'étude Retrospective Studies Maladies Bone marrow failure Groupe Severe Aplastic Anaemia Working Party (SAAWP) Type de traitement Allogeneic Investigateur principal Stijn Halkes
RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients Type d'étude Non-interventional Prospective Studies Maladies Bone marrow failure Groupe Severe Aplastic Anaemia Working Party (SAAWP) Type de traitement Immunosuppressive Treatment (IST) Investigateur principal Régis Peffault de Latour, Antonio M. Risitano
Real life analysis BV use as consolidation therapy in HL with high risk post ASCT Type d'étude Retrospective Studies Maladies Hodgkin’s Disease (HD) Groupe Lymphoma Working Party (LWP) Type de traitement Autologous Investigateur principal Mariana Bastos Oreiro
Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis. Type d'étude Retrospective Studies Maladies Hodgkin’s Disease (HD) Groupe Lymphoma Working Party (LWP) Type de traitement Allogeneic Investigateur principal Miguel-Angel Perales
Allogeneic Stem Cell TransplantationIn NK/ T-cell lymphoma Type d'étude Retrospective Studies Maladies Groupe Lymphoma Working Party (LWP) Type de traitement Allogeneic Investigateur principal Norbert Schmitz
Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis Type d'étude Retrospective Studies Maladies Groupe Cellular Therapy & Immunobiology Working Party (CTIWP) Type de traitement Investigateur principal Jacopo Peccatori
Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) Type d'étude Retrospective Studies Maladies Auto immune disorders Groupe Autoimmune Diseases Working Party (ADWP) Type de traitement Investigateur principal Tobias Alexander
Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis Type d'étude Retrospective Studies Maladies Auto immune disorders Groupe Autoimmune Diseases Working Party (ADWP) Type de traitement Autologous Investigateur principal Riccardo Saccardi
Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST) Type d'étude Non-interventional Prospective Studies Maladies Auto immune disorders Groupe Autoimmune Diseases Working Party (ADWP) Type de traitement Autologous Investigateur principal Riccardo Saccardi
Outcomes of HSCT for autoimmune cytopenias (AIC): a Retrospective Registry Study from the Autoimmune Diseases Working Party (ADWP) and the Paediatric Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Type d'étude Retrospective Studies Maladies Auto immune disorders Groupe Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) Type de traitement Investigateur principal Nichola Cooper